期刊論文| 1. | Seshadri, S.、Beiser, A.、Selhub, J.(2002)。Plasma homocysteine as a risk factor for dementia and Alzheimer's disease。N Engl J Med，346，476-483。   |
| 2. | Olanow, C. W.、Watts, R. L.、Koller, W. C.(2001)。An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines。Neurology，56(11)，S1-S88。 |
| 3. | 劉弘仁、黃正平(20020400)。老年憂鬱症。臨床醫學，49(4)=292，227-233。 延伸查詢 |
| 4. | 呂淑妤、林宗義(20000200)。南部社區老人憂鬱症狀盛行率及相關因素研究。中華公共衛生雜誌，19(1)，50-60。 延伸查詢 |
| 5. | Horrobin, D. F.、Bennett, C. N.(1999)。Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes。Prostaglandins Leukot Essent Fatty Acids，60，217-234。 |
| 6. | Ueki, A.、Otsuka, M.(2004)。Life style risks of Parkinson's disease: Association between decreased water intake and constipation。Journal of Neurology，251(Suppl 7)，vII18-vII23。 |
| 7. | Pennington, J. A. T.(1998)。Dietary exposure models for nitrates and nitrites。Food Control，9，385-395。 |
| 8. | 傅振宗、曾良達、李志成(19880300)。Correlates of CES-D Depressive Scores in the Elderly of a Rural Community。臺灣醫學會雜誌，87(3)，365-368。 延伸查詢 |
| 9. | Chong, M. Y.、Tsang, H. Y.、Chen, C. S.(2001)。Community study of depression in old age in Taiwan: prevalence, life events and socio-demographic correlates。The British Journal of Psychiatry，178，29-35。 |
| 10. | Stoll, A. L.、Severus, W. E.、Freeman, M. P.(1999)。Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial。Arch Gen Psychiatry，56，407-412。 |
| 11. | Luchsinger, J. A.、Mayeux, R.(2004)。Dietary factors and Alzheimer's disease。Lancet Neurology，3(10)，579-587。 |
| 12. | Bowman, G. L.(2012)。Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging。Neurology，78，241-249。 |
| 13. | Kesse-Guyot, E.(2012)。A healthy dietary pattern at midlife is associated with subsequent cognitive performance。J Nutr，142，909-915。 |
| 14. | Valls-Pedret, C.(2012)。Polyphenol-rich foods in the Mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk。J Alzheimers Dis，29(4)，773-782。 |
| 15. | Agrawal, R.、Gomez-Pinilla, F.(2012)。'Metabolic syndrome' in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition。J Physiol，590，2485-2499。 |
| 16. | Barrett, E. J.(2009)。The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action。Diabetologia，52，752-764。 |
| 17. | Webb, A. J.(2008)。Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite。Hypertension，51，784-790。 |
| 18. | Presley, T. D.、Morgan, A. R.、Bechtold, E.、Clodfelter, W.、Dove, R. W.、Jennings, J. M.、Rejeski, W. J.(2011)。Acute effect of a high nitrate diet on brain perfusion in older adults。Nitric Oxide，24(1)，34-42。 |
| 19. | McKnight, G. M.、Duncan, C. W.、Leifert, C.(1999)。Dietary nitrate in man: friend or foe?。Br J Nutr，81，349-358。 |
| 20. | Lundberg, J. O.、Feelisch, M.、Björne, H.(2006)。Cardioprotective effects of vegetables: is nitrate the answer?。Nitric Oxide，15，359-362。 |
| 21. | Hord, N. G.、Tang, Y.、Bryan, N. S.(2009)。Food sources of nitrates and nitrites: the physiologic context for potential health benefits。Am J Clin Nutr，90，1-10。 |
| 22. | Santamaria, P.(2001)。Ways of reducing rocket salad nitrate content。Acta Home，548，529-537。 |
| 23. | Anjana, S. U. I. M.、Abrol, Y. P.(2007)。Are nitrate concentrations in leafy vegetables within safe limits?。Curr Sci，92，355-360。 |
| 24. | Santamaria, P.(2006)。Nitrate in vegetables: toxicity, content, intake and EC regulation。J Sci Food Agric，86，10-17。 |
| 25. | Launer, L. J.(1992)。Overview of Incidence Studies of Dementia Conducted in Europe。Neuroepidemiology，11，2-13。 |
| 26. | World Health Organization(1999)。World Health Day will focus on ageing。Bulletin of the World Health Organization，77，293-294。 |
| 27. | Agronin, M. E.(1998)。Personality and psychopathology in late life。Geriatrics，53(Suppl 1)，S35-S40。 |
| 28. | Chui, H. C.、Victoroff, J. I.、Jagust, W.(1992)。Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s disease diagnostic and treatment centers。Neurology，42，473-480。 |
| 29. | Ramirez-Lassepas, M.(1998)。Stroke and the aging of the brain and the arteries。Geriatrics，53，S44-S48。 |
| 30. | Wolfram, G.(1995)。Diet therapy in gout。Therapeutische Umshau，52，524-527。 |
| 31. | Tang, J. L.、Armitage, J. M.、Lancaster, T.(1998)。Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects。Br J Nutr，316(7139)，1213-1220。 |
| 32. | González-Gross, M.(2001)。Nutrition and cognitive impairment in the elderly。Br J Nutr.，86(3)，313-321。 |
| 33. | Harman, D.(1995)。Free radical theory of aging: Alzheimer's disease pathogenesis。Age，18，97-119。 |
| 34. | Hendrie, H. C.、Osuntokun, B. O.、Hall, K. S.(1995)。Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans。Am J Psychiatry，152，1485-1492。 |
| 35. | Graves, A. B.、Larson, E. B.、Edland, S. D.(1996)。Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame Project。Am J Epidemiol，144，760-771。 |
| 36. | White, L.(1996)。Prevalence of dementia in older Japanese-American men in Hawaii。J Am Med Assoc，276，955-960。 |
| 37. | Hulette, C.、Nochlin, D.、McKeel, D.(1997)。Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases。Neurol，48，668-672。 |
| 38. | Snowdon, D. A.、Greiner, L. H.、Mortimer, J. A.(1997)。Brain infarction and the clinical expression of Alzheimer's disease. The Nun Study。JAMA，277，811-817。 |
| 39. | Clausen, J.(1984)。Demential syndromes and the lipid metabolism。Acta Neurol Scand，70，345-355。 |
| 40. | Harman, D.(1994)。Aging: prospects for further increases in the functional lifespan。Age，17，119-146。 |
| 41. | Smith, M. A.、Perry, G.(1995)。Free radical damage, iron and Alzheimer's disease。J Neurol Sci，134(suppl)，92-94。 |
| 42. | Davis, R. E.(1997)。Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease。Proc Nat Acad Sci USA，94，4526-4531。 |
| 43. | Elias, M. F.(1998)。Effects of chronic hypertension on cognitive functioning。Geriatrics，53，S49-S52。 |
| 44. | Skoog, I.、Lemfelt, B.、Landahl, S.(1996)。15-year longitudinal study of blood pressure and dementia。Lancet，347，1141-1145。 |
| 45. | Gale, C. R.、Martyn, C. N.、Cooper, C.(1996)。Cognitive impairment and mortality in a cohort of elderly people。Br Med J.，312，608-611。 |
| 46. | Moroney, J. T.、Tang, M. X.、Berglund, L.(1999)。Low-density lipoprotein cholesterol and the risk of dementia with stroke。J Am Med Associ.，282，254-260。 |
| 47. | Notkola, I. L.、Sulkava, R.、Pekkanen, J.(1998)。Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease。Neuroepidemiology，17，14-20。 |
| 48. | Puglielli, L.、Tanzi, R.、Kovacs, D.(2003)。Alzheimer's disease: the cholesterol connection。Nature Neurosci.，6，345-351。 |
| 49. | Trkanjec, Z.、Bene, R.(2009)。Serum HDL, LDL and total cholesterol in patients with late-life onset of Alzheimer's disease versus vascular dementia。Acta Clin Croat，48(3)，259-263。 |
| 50. | Greenwood, C. E.、Winocur, G.(1996)。Cognitive impairment in rats fed high-fat diets: a specific effect of saturated fatty-acid intake。Behav Neurosci.，110，451-459。 |
| 51. | Refolo, L. M.、Malester, B.、LaFrancois, J.(2000)。Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model。Neurobiol Dis.，7，321-331。 |
| 52. | Jick, H.、Zornberg, G. L.、Jick, S. S.(2000)。Statins and the risk of dementia。Lancet，356，1627-1631。 |
| 53. | Wolozin, B.、Kellman, W.、Ruosseau P.(2000)。Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors。Arch Neurol.，57，1439-1443。 |
| 54. | Shichita, T.、Sugiyama, Y.、Ooboshi, H.(2009)。Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury。Nat Med.，15(8)，946-950。 |
| 55. | Aisen, P. S.、Davis, K. L.(1997)。The search for disease-modifying treatment for Alzheimer's disease。Neurol，48(Suppl 6)，S35-S41。 |
| 56. | Stewart, W. F.、Kawas, C.、Corrada, M.(1997)。Risk of Alzheimer's disease and duration of NSAID use。Neurol，48，626-632。 |
| 57. | Harman, D.(1996)。Aging and disease: extending functional life span。Ann N Y Acad Sci，786，321-336。 |
| 58. | Cohn, J. S.(2002)。Oxidized fat in the diet, postprandial lipaemia and cardiovascular disease。Curr Opin Lipidol，13，19-24。 |
| 59. | Morris, M. C.、Evans, D. A.、Bienias, J. L.(2003)。Dietary fats and the risk of incident Alzheimer disease。Arch Neurol.，60，194-200。 |
| 60. | Bray, G. A.、Lovejoy, J. C.、Smith, S. R.(2002)。The influence of different fats and fatty acids on obesity, insulin resistance and inflammation。J Nutr，132，2488-2491。 |
| 61. | Yan, S. D.、Schmidt, A. M.、Anderson, G. M.(1994)。Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins。J Biol Chem，269，9889-9897。 |
| 62. | Smith, M. A.、Sayre, L.、Perry, G.(1996)。Diabetes mellitus and Alzheimer's disease: Glycation as a biochemical link。Diabetologia，39。 |
| 63. | Finch, C. E.、Cohen, D. M.(1997)。Aging, metabolism, and Alzheimer disease: Review and hypotheses。Experiment Neurol，143，82-102。 |
| 64. | Yan, S. D.(1997)。Amyloid-β peptide: Receptor for Advanced Glycation Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease。Proc Natl Acad Sci USA，94，5296-5301。 |
| 65. | Su, H. M.(2010)。Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance。J Nutr Biochem，21(5)，364-373。 |
| 66. | Conquer, J. A.、Tierney, M. C.、Zecevic, J.(2000)。Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment。Lipids，35，1305-1312。 |
| 67. | Corrigan, F. M.、Horrobin, D. F.、Skinner, E. R.(1998)。Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content。Int J Biochem Cell Biol.，30，197-207。 |
| 68. | Morris, M. C.(2009)。The role of nutrition in Alzheimer's disease: epidemiological evidence。Eur J Neurol，16(Suppl 1)，1-7。 |
| 69. | Butterfield, D. A.(1996)。Alzheimer's disease: a disorder of oxidative stress。Alzheimer's Dis Rev，1，68-70。 |
| 70. | Logroscino, G.、Marder, K.、Cote, L.(1996)。Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study。Ann Neurol.，39，89-94。 |
| 71. | Smith, M. A.、Sayre, L.、Perry, G.(1996)。Is Alzheimer's a. disease of oxidative stress?。Alzheimer's Dis Rev，1，63-67。 |
| 72. | Jiang, Q.、Ames, B. N.(2003)。Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats。FASEB J.，17，816-822。 |
| 73. | Homocysteine Studies Collaboration(2002)。Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis。JAMA，288，2015-2022。 |
| 74. | González-Gross, M.、Marcos, A.、Pietrzik, K.(2001)。Nutrition and cognitive impairment in the elderly。Br J Nutr.，86，313-321。 |
| 75. | Selhub, J.、Jacques, P. F.、Wilson, P. W.(1993)。Vitamin status and intake as primary determinants of homocysteinemia in an elderly population。JAMA，270，2693-2698。 |
| 76. | Gu, Y.、Nieves, J. W.、Stern, Y.(2010)。Food combination and Alzheimer disease risk: a protective diet。Arch Neurol.，67(6)，699-706。 |
| 77. | Scarmeas, N.、Stern, Y.、Tang, M. X.(2006)。Mediterranean diet and risk for Alzheimer's disease。Ann Neurol.，59(6)，912-921。 |
| 78. | Scarmeas, N.、Stern, Y.、Mayeux, R.(2006)。Mediterranean diet, Alzheimer disease, and vascular mediation。Arch Neurol.，63，1709-1717。 |
| 79. | Lutz, J.(1984)。Calcium balance and acid-base status of women as affected by increased protein intake and by sodium bicarbonate ingestion。Am J Clin Nutr.，39，281-288。 |
| 80. | Hegsted, D. M.(1986)。Calcium and osteoporosis。J Nutr.，116，2316-2319。 |
| 81. | Metz, J. A.、Anderson, J. J. B.、Gallagher, P. N. Jr.(1993)。Intakes of calcium, phosphorus, and protein, and physical-ac-tivity level are related to radial bone mass in young adult women。Am J Clin Nutr.，58，537-542。 |
| 82. | Massey, L. K.、Whiting, S. J.(1993)。Caffeine, urinary calcium, calcium metabolism and bone。J Nutr，123，1611-1614。 |
| 83. | Nordin, B. E. C.、Need, A. G.、Morris, H. A.(1993)。The nature and significance of the relationship between urinary sodium and urinary calcium in women。J Nutr，123，1615-1622。 |
| 84. | Reinhold, J. G.(1971)。High phytate content of rural Iranian bread: a possible cause of human zinc deficiency。Am J Clin Nutr.，24，1204-1206。 |
| 85. | Wills, M. R.(1973)。Intestinal absorption of calcium。Lancet，1，820-822。 |
| 86. | Ehmann, W. D.、Markesbery, W. R.、Alauddin, M.(1986)。Brain trace elements in Alzheimer's disease。Neurotoxicol.，7，197-206。 |
| 87. | Thompson, C. M.、Markesbery, W. R.、Ehmann, W. D.(1988)。Regional brain trace element studies in Alzheimer's disease。Neuro Toxicol.，9，1-8。 |
| 88. | Wenstrup, D.、Ehmann, W. D.、Markesbery, W. R.(1990)。Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains。Brain Res.，533，125-131。 |
| 89. | Savory, J.、Exley, C.、Forbes, W. F.(1996)。Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?。J Toxicology and Environ Health，48，615-635。 |
| 90. | Von Arnim, C. A.、Gola, U.、Biesalski, H. K.(2010)。More than the sum of its parts? Nutrition in Alzheimer's disease。Nutrition，26(7/8)，694-700。 |
| 91. | Nelson, C.、Wengreen, H. J.、Munger, R. G.(2009)。Dietary folate, vitamin B-12, vitamin B-6 and incident Alzheimer's disease: the cache county memory, health and aging study。J Nutr Health Aging，13(10)，899-905。 |
| 92. | Heinonen, I. M.、Lehtonen, P. J.、Hopia, A. I.(1998)。Antioxidant Activity of Berry and Fruit Wines and Liquors。J Agric Food Chem.，46，25-31。 |
| 93. | Sun, A. Y.、Wang, Q.、Simonyi, A.(2010)。Resveratrol as a therapeutic agent for neurodegenerative diseases。Mod Neurobiol.，41(2/3)，375-383。 |
| 94. | Ho, L.、Chen, L. H.、Wang, J.(2009)。Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration。J Alzheimer's Dis.，16(1)，59-72。 |
| 95. | Karuppagounder, S. S.、Pinto, J. T.、Xu, H.(2009)。Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease。Neurochem Int.，54(2)，111-118。 |
| 96. | Delgado, P. L.(2000)。Depression: the case for a monoamine deficiency。J Clin Psychiatry，61(Suppl 6)，7-11。 |
| 97. | Wig, N. N.(2001)。World Health Day, 2001。Indian J Psychiatry，43，1-4。 |
| 98. | Liu, C. Y.、Wang, S. J.、Teng, E. L.、Fuh, J. L.、Lin, C. C.、Lin, K. N.(1997)。Depressive disorders among older residents in a Chinese rural community。Psychol Med.，27，943-949。 |
| 99. | 吳佳璇、李信謙、李明濱、李宇宙、曾美智、陳映燁(20010600)。老年憂鬱症住院病人之臨床特徵。臺灣精神醫學，15(2)，50-58。 延伸查詢 |
| 100. | 林正介、李燕鳴、劉樹泉(19950300)。影響新店社區老人憂鬱情緒之因素。中華民國家庭醫學雜誌，5(1)，1-11。 延伸查詢 |
| 101. | Saunders, P. A.、Copeland, J. R. M.、Dewey, M. E.(1993)。The prevalence of dementia, depression and neurosis in later life: the Liverpool MRC-ALPHA Study。Int J Epidemiology，22，838-847。 |
| 102. | Lauter, H.、Dame, S.(1991)。Depressive disorders and dementia: the clinical view。Acta Psychiatr Psuchiatr Scand，83(s366)，40-46。 |
| 103. | Tiemeier, H.、Van Tuijl, H. R.、Hofman, A.(2003)。Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study。Am J Clin Nutr.，78，40-46。 |
| 104. | Ellison, L. F.、Morrison, H. I.(2001)。Low serum cholesterol concentration and risk of suicide。Epidemiology，12，168-172。 |
| 105. | Farmer, M. E.、Locke, B. Z.、Mościcki, E. K.(1988)。Physical activity and depressive symptoms: the NHANES I Epidemiologic Follow-up Study。Am J Epidemiol.，128(6)，1340-1351。 |
| 106. | Skarupski, K. A.、Tangney, C.、Li, H.(2010)。Longitudinal association of vitamin B-6, folate, and vitamin B-12 with depressive symptoms among older adults over time。Am J Clin Nutr.，92，330-335。 |
| 107. | Bertone-Johnson, E. R.、Powers, S. I.、Spangler, L.(2011)。Vitamin D intake from foods and supplements and depressive symptoms in a diverse population of older women。Am J Clin Nutr.，94(4)，1104-1112。 |
| 108. | Hibbeln, J. R.(1998)。Fish consumption and major depression。Lancet，351。 |
| 109. | Tanskanen, A.、Hibbeln, J. R.、Tuomilehto, J.(2001)。Fish consumption and depressive symptoms in the general population in Finland。Psychiatr Serv.，52，529-531。 |
| 110. | Tanskanen, A.、Hibbeln. J. R.、Hintikka, J.(2001)。Fish consumption, depression, and suicidality in a general population。Arch Gen Psychiatry，58，512-513。 |
| 111. | Chiu, C. C.、Huang, S. Y.、Shen, W. W.(2003)。Omega-3 fatty acids for depression in pregnancy。Am J Psychiatry，160。 |
| 112. | Nemets, H.、Nemets, B.、Apter, A.(2006)。Omega-3 treatment of childhood depression: a controlled, double-blind pilot study。Am J Psychiatry，163，1098-1100。 |
| 113. | Nemets, B.、Stahl, Z.、Belmaker, R. H.(2002)。Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder。Am J Psychiatry，159，477-479。 |
| 114. | Peet, M.、Horrobin, D. F.(2002)。A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs。Arch Gen Psychiatry，59，913-919。 |
| 115. | Lin, P. Y.、Su, K. P.(2007)。A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids。J Clin Psychiatry，68，1056-1061。 |
| 116. | Marangell, L. B.、Martinez, J. M.、Zboyan, H. A.(2003)。A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression。Am J Psychiatry，160，996-998。 |
| 117. | Silvers, K. M.、Woolley, C. C.、Hamilton, F. C.(2005)。Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression。Prostaglandins Leukot Essent Fatty Acids，72，211-218。 |
| 118. | Frasure-Smith, N.、Lespérance, F.、Julien, P.(2004)。Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes。Biol Psychiatry，55，891-896。 |
| 119. | Sublette, M. E.、Hibbeln, J. R.、Galfalvy, H.(2006)。Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk。Am J Psychiatry，163，1100-1102。 |
| 120. | Lucas, M. J.、Mirzaei, F.、O'Reilly, E.(2011)。Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study。Am J Clin Nutr.，93(6)，1337-1343。 |
| 121. | Hibbeln, J. R.、Salem, N. Jr.(1995)。Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy。Am J Clin Nutr.，62，1-9。 |
| 122. | Chalon, S.(2006)。Omega-3 fatty acids and monoamine neurotransmission。Prostaglandins Leukot Essent Fatty Acids，75，259-269。 |
| 123. | Rapoport, S. I.、Bosetti, F.(2002)。Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?。Arch Gen Psychiatry，59，592-596。 |
| 124. | Farooqui, A. A.、Ong, W. Y.、Horrocks, L. A.(2006)。Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders。Pharmacol Rev.，58，591-620。 |
| 125. | Hypericum Depression Trial Study Group(2002)。Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial。JAMA，287，1807-1814。 |
| 126. | Greeson, J. M.、Sanford, B.、Monti, D. A. S.(2000)。St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature。Psychopharmacology，153，402-414。 |
| 127. | Bower, J. H.、Maraganore, D. M.、McDonnell, S. K.(1999)。Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990。Neurology，52，1214-1220。 |
| 128. | Baldereschi, M.、Di Carlo, A. D.、Rocca, W. A.(2000)。Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging。Neurology，55，1358-1363。 |
| 129. | Semchuk, K. M.、Love, E. J.、Lee, R. G.(1993)。Parkinson's disease: a test of the multifactorial etiologic hypothesis。Neurology，43，1173-1180。 |
| 130. | Sim, E.、Stanley, L. A.、Risch, A.(1995)。Xenogenetics in multifactorial disease susceptibility。Trends Genet.，11，509-512。 |
| 131. | Taylor, C. A.、Saint-Hilaire, M. H.、Cupples, L. A.(1999)。Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study。Am J Med Genet.，88，742-749。 |
| 132. | Duan, W.、Mattson, M. P.(1999)。Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease。J Neurosci Res.，57，195-206。 |
| 133. | Holmer, H. K.、Keyghobadi, M.、Moore, C.(2005)。Dietary restriction affects striatal glutamate in the MPTP‐induced mouse model of nigrostriatal degeneration。Synapse，57，100-112。 |
| 134. | Mattson, M. P.(2003)。Will caloric restriction and folate protect against AD and PD?。Neurology，60，690-695。 |
| 135. | Mattson, M. P.、Duan, W.、Wan, R.、Guo, Z.(2004)。Prophylactic Activation of Neuroprotective Stress Response Pathway by Dietary and Behavioral Manipulations。Neuro Rx.，1，111-116。 |
| 136. | Anderson, C.、Checkoway, H.、Franklin, G. M.(1999)。Dietary factors in Parkinson's disease: the role of food groups and specific foods。Mov Disord，14，21-27。 |
| 137. | Johnson, C. C.、Gorell, J. M.、Rybicki, B. A.(1999)。Adult nutrient intake as a risk factor for Parkinson's disease。Int J Epidemiol，28，1102-1109。 |
| 138. | Hellenbrand, W.、Seidler, A.、Boeing, H.(1996)。Diet and Parkinson's disease. I: A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study。Neurology，47，636-643。 |
| 139. | Logroscino, G.、Mayeux, R.(1997)。Diet and Parkinson's disease。Neurology，49，310-311。 |
| 140. | Chen, H.、Zhang, S. M.、Hernán, M. A.(2003)。Weight loss in Parkison's Disease。Ann Neurol.，53，676-679。 |
| 141. | Mattson, M. P.(2003)。Gene-diet interactions in brain aging and neurodegenerative disorders。Ann Intern Med.，139，441-444。 |
| 142. | Abbott, R. D.、Ross, G. W.、White, L. R.(2003)。Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study。J Neurol.，250(suppl 3)，III30-III39。 |
| 143. | Scheider, W. L.、Hershey, L. A.、Vena, J. E.(1997)。Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease。Mov Disord，12，190-196。 |
| 144. | Chen, H.、Zhang, S. M.、Hernán, M. A.(2002)。Diet and Parkinson's disease: A potential role of dairy products in men。Ann Neurol.，52，793-801。 |
| 145. | Chen, H.、Zhang, S. M.、Hernán, M. A.(2003)。Dietary intakes of fat and risk of Parkinson's disease。Am J Epidemiol.，157，1007-1014。 |
| 146. | Hellenbrand, W.、Boeing, H.、Robra, B. P.(1996)。Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study。Neurology，47，644-650。 |
| 147. | Powers, K. M.、Smith-Weller, T.、Franklin, G. M.(2003)。Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes。Neurology，60，1761-1766。 |
| 148. | Logroscino, G.、Marder, K.、Graziano, J.(1998)。Dietary iron, animal fats, and risk of Parkinson's disease。Mov Disord，13(suppl 1)，13-16。 |
| 149. | Fall, P. A.、Fredrikson, M.、Axelson, O.(1999)。Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden。Mov Disord，14，28-37。 |
| 150. | Berg, D.、Gerlach, M.、Youdim, M. B.(2001)。Brain iron pathways and their relevance to Parkinson's disease。J Neurochem，79，225-236。 |
| 151. | Mann, V. M.、Cooper, J. M.、Daniel, S. E.(1994)。Complex I, iron, and ferritin in Parkinson's disease substantia nigra。Ann Neurol，36，876-881。 |
| 152. | Bocca, B.、Alimonti, A.、Senofonte, O.(2006)。Metal changes in CSF and peripheral compartments of parkinsonian patients。J Neurol Sci.，248，23-30。 |
| 153. | Zhang, S. M.、Hernán, M. A.、Chen, H.(2002)。Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk。Neurology，59，1161-1169。 |
| 154. | De Lau, L. M.、Bornebroek, M.、Witteman, J. C.(2005)。Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study。Neurology，64，2040-2045。 |
| 155. | De Lau, L. M.、Koudstaal, P. J.、Witteman, J. C.(2006)。Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease。Neurology，67，315-318。 |
| 156. | Kuhn, W.、Roebroek, R.、Blom, H.(1998)。Hyperhomocysteinemia in Parkinson's disease。J Neurol.，245，811-812。 |
| 157. | Chen, H.、Zhang, S. M.、Schwarzschild, M. A.(2004)。Folate intake and risk of Parkinson's disease。Am J Epidemiol.，160，368-375。 |
| 158. | Golbe, L. I.、Farrell, T. M.、Davis, P. H.(1998)。Case-control study of early life dietary factors in Parkinson's disease。Arch Neurol.，45，1350-1355。 |
| 159. | Golbe, L. I.、Farrell, T. M.、Davis, P. H.(1990)。Follow-up study of early-life protective and risk factors in Parkinson's disease。Mov Disord，5，66-70。 |
| 160. | Butterfield, P. G.、Valanis, B. G.、Spencer, P. S.(1993)。Environmental antecedents of young-onset Parkinson's disease。Neurology，43，1150-1158。 |
| 161. | Etminan, M.、Gill, S. S.、Samii, A.(2005)。Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis。Lancet Neurol.，4，362-365。 |
| 162. | De Rijk, M. C.、Breteler, M. M.、Den Breeijen, J. H.(1997)。Dietary antioxidants and Parkinson's disease. The Rotterdam Study。Arch Neurol.，54，762-765。 |
| 163. | Tanner, C. M.、Cohen, J. A.、Summerville, B. C.(1988)。Vitamin use and Parkinson's disease。Ann Neurol.，23。 |
| 164. | Cerhan, J. R.、Wallace, R. B.、Folsom, A. R.(1994)。Antioxidant intake and risk of Parkinson's Disease in older women。Am J Epidemiol.，139。 |
| 165. | Weinreb, O.、Mandel, S.、Amit, T.(2004)。Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases。J Nutr Biochem.，15，506-516。 |
| 166. | Moskaug, J. Ø.、Carlsen, H.、Myhrstad, M. C.(2005)。Polyphenols and glutathione synthesis regulation。Am J Clin Nutr.，81，277S-283S。 |
| 167. | Manach, C.、Scalbert, A.、Morand, C.、Rémésy, C.、Jiménez, L.(2004)。Polyphenols: food sources and bioavailability。The American Journal of Clinical Nutrition，79(5)，727-747。 |
| 168. | Tan, E. K.、Tan, C.、Fook-Chong, S. M.(2003)。Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese。J Neurol Sci.，216，163-167。 |
| 169. | Checkoway, H.、Powers, K.、Smith-Weller, T.(2002)。Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake。Am J Epidemiol.，155，732-738。 |
| 170. | Ross, G. W.、Abbott, R. D.、Petrovitch, H.(2000)。Association of coffee and caffeine intake with the risk of Parkinson disease。JAMA，283，2674-2679。 |
| 171. | Benedetti, M. D.、Bower, J. H.、Maraganore, D. M.(2000)。Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study。Neurology，55，1350-1358。 |
| 172. | Ross, G. W.、Abbott, R. D.、Petrovitch, H.(2000)。Relationship between caffeine intake and parkinson disease。JAMA，284，1378-1379。 |
| 173. | Ascherio, A.、Chen, H.、Schwarzschild, M. A.(2003)。Caffeine, postmenopausal estrogen, and risk of Parkinson's disease。Neurology，60，790-795。 |
| 174. | Lewerin, C.、Matousek, M.、Steen, G.(2005)。Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study。Am J Clin Nutr.，81，1155-1162。 |
| 175. | Sclater, A.(2004)。Orthostatic hypotension. A primary care primer for assessment and treatment。Geriatrics，59，22-27。 |
| 176. | Vloet, L. C. M.(2001)。The influence of low-, normal-, and high-carbohydrate meals on blood pressure in elderly patients with postprandial hypotension。J Gerontol A Biol Sci Med Sci.，56A，M744-M748。 |
| 177. | Jansen, R. W.(1995)。Postprandial hypotension: epidemiology, pathophysiology, and clinical management。Ann Intern Med.，122，286-295。 |
| 178. | Brown, R. T.(1989)。Euglycemic insulin-induced hypotension in autonomic failure。Clin Neuropharmacol.，12，227-231。 |
| 179. | Young, T. M.(2004)。The effects of water ingestion on orthostatic hypotension in two groups of chronic autonomic failure: multiple system atrophy and pure autonomic failure。J Neurology Neurosurg Psychiatry，75，1737-1741。 |
| 180. | Alagiakrishnan, K.(2007)。Postural and Postprandial Hypotension: Approach to Management。Geriatrics and Aging，10(5)，298-304。 |
| 181. | Marczewska, A.(2006)。Protein intake in Parkinsonian patients using the EPIC food frequency questionnaire。Movement Disorders，21(8)，1229-1231。 |
| 182. | Lorefät, B.(2006)。Food habits and intake of nutrients in elderly patients with Parkinson's disease。Gerontology，52(3)，160-168。 |
| 183. | Pathak, A.(2006)。Blood pressure disorders during Parkinson's disease: epidemiology, pathophysiology and management。Expert Rev Neurother.，6(8)，1173-1180。 |
| 184. | Vaitkevicius, P. V.(1991)。Frequency and importance of postprandial blood pressure reduction in elderly nursing-home patients。Ann Intern Med.，115，865-870。 |
| 185. | Staneczek, O.(2001)。A full stomach but an empty head。J Am Geriatr Soc.，49，1262-1263。 |
| 186. | Sauleau, P.、Leray, E.、Rouaud, T.(2009)。Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease。Mov Disord.，24(14)，2149-2155。 |
| 187. | Barichella, M.、Marczewska, A. M.、Mariani, C.(2003)。Body weight gain rate in patients with Parkinson's disease and deep brain stimulation。Mov Disord，18(11)，1337-1340。 |
| 188. | Guimarães, J.、Matos, E.、Rosas, M. J.(2009)。Modulation of nutritional state in Parkinsonian patients with bilateral subthalamic nucleus stimulation。J Neurol.，256(12)，2072-2078。 |
| 189. | Carter, J. H.、Nutt, J. G.、Woodward, W. R.(1989)。Amount and distribution of dietary protein affects clinical response to levodopa in Parkinson's disease。Neurology，39，552-556。 |
| 190. | Frankel, J. P.、Kempster, P. A.、Bovingdon, M.(1989)。The effects of oral protein on the absorption of intraduodenal levodopa and motor performance。J Neurol Neurosurg Psychiatry，52(9)，1063-1067。 |
| 191. | Juncos, J. L.、Fabbrini, G.、Mouradian, M. M.(1987)。Dietary influences on the antiparkinsonian response to levodopa。Arch Neurol.，44(10)，1003-1005。 |
| 192. | Pincus, J. H.、Barry, K. M.(1987)。Plasma levels of amino acids correlate with motor fluctuations in parkinsonism。Arch Neurol.，44(10)，1006-1009。 |
| 193. | Tsui, J. K.、Ross, S.、Poulin, K.(1989)。The effect of dietary protein on the efficacy of L-dopa: a double-blind study。Neurology，39(4)，549-552。 |
| 194. | Mena, I.、Cotzias, G. C.(1975)。Protein Intake and Treatment of Parkinson's Disease with Levodopa。N Engl J Med.，292，181-184。 |
| 195. | Gillespie, N. G.、Mena, I.、Cotzias, G. C.(1973)。Diets affecting treatment of parkinsonism with levodopa。J Am Diet Assoc.，62，525-528。 |
| 196. | Pincus, J. H.、Barry, K.(1988)。Protein redistribution diet restores motor function in patients with dopa-resistant "off" periods。Neurology，38，481-483。 |
| 197. | Barichella, M.、Marczewska, A.、De Notaris, R.(2006)。Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson's disease。Mov Disord，21(10)，1682-1687。 |
| 198. | Berry, E. M.、Growdon, J. H.、Wurtman, J. J.(1991)。A balanced carbohydrate protein diet in the management of Parkinson's disease。Neurology，41，1295-1297。 |
| 199. | Wade, D. N.、Mearrick, P. T.、Morris, J. L.(1973)。Active Transport of L-Dopa in the Intestine。Nature，242，463-465。 |
| 200. | Minami, H.、McCallum, R. W.(1984)。The physiology and pathophysiology of gastric emptying in humans。Gastroenterology，86，1592-1610。 |
| 201. | Rivera-Calimlim, L.、Dujovne, C. A.、Morgan, J. P.(1971)。Absorption and metabolism of L-dopa by the human stomach。Eur J Clin Invest.，1，313-320。 |
| 202. | Robertson, D. R. C.、Renwick, A. G.、Wood, N. D.(1990)。The influence of levodopa on gastric emptying in man。Br J Clin Pharmac.，29，47-53。 |
| 203. | Robertson, D. R.、Higginson, I.、Macklin, B. S.(1991)。The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers。Br J Clin Pharmacol.，31(4)，413-417。 |
| 204. | Verhoef, P.、De Groot, L. C.(2005)。Dietary determinants of plasma homocysteine concentrations。Semin Vasc Med.，5，110-123。 |
| 205. | Lamberti, P.、Zoccolella, S.、Armenise, E.(2005)。Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration。Eur J Neurol.，12，365-368。 |
| 206. | Di Stefano, A.、Sozio, P.、Cocco, A.(2006)。L-dopa- and dopamine-(R)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties。J Med Chem.，49，1486-1493。 |
| 207. | Kempster, P. A.、Wahlqvist, M. L.(1994)。Dietary factors in the management of Parkinson's disease。Nutr Rev.，52(2 pt 1)，51-58。 |
| 208. | Smith, Ruth S.(1991)。The Macrophage theory of depression。Medical Hypotheses，35，298-306。 |